We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of more than 30 consumer, health and trade organizations urged three dozen countries — including the U.S. — to allow imports of drugs manufactured under government-issued patent exemptions during the COVID-19 crisis. Read More
The Drug Enforcement Administration (DEA) is allowing increased production and importation of some controlled medicines to address the surge in demand for drugs needed for COVID-19 patients on ventilators. Read More
The FDA hit Pennsauken, New Jersey drugmaker Cetylite Industries with a Form 483 for multiple GMP failures and the lack of annual product reviews. Read More
The World Health Organization’s director-general has endorsed the voluntary sharing of patent rights and pooling of data to help develop COVID-19 drugs. Read More
Eli Lilly yesterday introduced a $35 monthly insulin co-pay for patients with or without commercial insurance to ensure they have access to the diabetes drug during the COVID-19 crisis. Read More
The Indian government said Tuesday that it will lift its newly imposed export restriction on the anti-malaria drug hydroxychloroquine, a potential COVID-19 treatment. Read More